Skip to main content
Clinical Trials/NL-OMON39499
NL-OMON39499
Completed
Phase 3

An efficacy, safety and pharmacokinetic study on the short-term and long-term use of METFORMIN in obese children and adolescents. - Metformin in obese children and adolescents

Sint Antonius Ziekenhuis0 sites144 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Bariatrie (Obesitas)
Sponsor
Sint Antonius Ziekenhuis
Enrollment
144
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria are subject\*s age \>\= 10 and \<\= 16 years at study entry, from Caucasian descent, with obesity defined as BMI SDS \> 2\.3 and with insulin resistance defined as HOMA\-IR \>\= 3\.4\. In addition an obtained informed consent from subjects and/or parents/caregivers.

Exclusion Criteria

  • The exclusion criteria are presence of T2DM (American Diabetes Association criteria); presence of endocrine disorders with steroid therapy; suspicion of polycystic ovarium syndrome; height \< \-1\.3 SD of target height; psychiatric illness and eating disorders in particular; use of anti\-hyperglycaemic drugs; pregnancy (pregnancy test will be performed, if applicable); (history of) alcohol abuse; impaired renal and/or hepatic function (defined as GFR\<80ml/min and ALAT \>\= 150% of normal value for age); use of ritonavir; use of ACE inhibitors; insufficient knowledge of the Dutch language.

Outcomes

Primary Outcomes

Not specified

Similar Trials